Use of PB-Cre4 Mice for Mosaic Gene Deletion

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Birbach, Andreas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; PROBASIN;

ALLELE; ANIMAL TISSUE; ARTICLE; CHROMOSOME 11Q; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENETIC RECOMBINATION; LOXP SITE; MALE; MOSAICISM; MOUSE; NONHUMAN; OVARY FOLLICLE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; FEMALE; GENETIC ENGINEERING; INTEGRASES; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MOSAICISM; OOCYTES; PROSTATE; RECOMBINATION, GENETIC; SEX FACTORS; TRANSGENES;

ANIMALIA; MUS;

EID: 84872144168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053501     Document Type: Article

References (20)

1. Houdebine LM, (2002) The methods to generate transgenic animals and to control transgene expression. J Biotechnol 98: 145-160.
2. Giraldo P, Montoliu L, (2001) Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res 10: 83-103.
3. Wu X, Wu J, Huang J, Powell WC, Zhang J, et al. (2001) Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101: 61-69.
4. Zhang J, Thomas TZ, Kasper S, Matusik RJ, (2000) A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 141: 4698-4710.
5. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, et al. (2003) Pten dose dictates cancer progression in the prostate. PLoS Biol 1: E59.
6. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, et al. (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221.
7. Kelavkar UP, Parwani AV, Shappell SB, Martin WD, (2006) Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia 8: 510-522.
8. Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, et al. (2006) Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 66: 7889-7898.
9. Maddison LA, Sutherland BW, Barrios RJ, Greenberg NM, (2004) Conditional deletion of Rb causes early stage prostate cancer. Cancer Res 64: 6018-6025.
10. Francis JC, McCarthy A, Thomsen MK, Ashworth A, Swain A, (2010) Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis. PLoS Genet 6: e1000995.
11. Pearson HB, Phesse TJ, Clarke AR, (2009) K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse. Cancer Res 69: 94-101.
12. Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, et al. (2007) Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res 67: 2490-2496.
13. Wu X, Xu K, Zhang L, Deng Y, Lee P, et al. (2011) Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism. Dev Biol 356: 337-349.
14. Suzuki A, Yamaguchi MT, Ohteki T, Sasaki T, Kaisho T, et al. (2001) T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14: 523-534.
15. Kawamoto S, Niwa H, Tashiro F, Sano S, Kondoh G, et al. (2000) A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett 470: 263-268.
16. Birbach A, Eisenbarth D, Kozakowski N, Ladenhauf E, Schmidt-Supprian M, et al. (2011) Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor model. Neoplasia 13: 692-703.
17. Siebert PD, Chenchik A, Kellogg DE, Lukyanov KA, Lukyanov SA, (1995) An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res 23: 1087-1088.
18. Birbach A, Casanova E, Schmid JA, (2009) A Probasin-MerCreMer BAC allows inducible recombination in the mouse prostate. Genesis 47: 757-764.
19. Ratnacaram CK, Teletin M, Jiang M, Meng X, Chambon P, et al. (2008) Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma. Proc Natl Acad Sci U S A 105: 2521-2526.
20. Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, et al. (2005) Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res 65: 5730-5739.